$4.48 -0.22 (-4.68%)
11/6/2009 4:00 PM

Molecular Insight Pharmaceuticals, Inc. (MIPI)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics designed to improve patient diagnosis, treatment and management.

Current Price $4.48 Mkt Cap $113.08M
Open $4.55 P/E Ratio 0.00
Prev. Close $4.70 Div. (Yield) N/A (N/A)
Daily Range $4.30 - $4.65 Volume 35,848
52-Wk Range $1.15 - $7.90 Avg. Daily Vol. 45,000

MIPI News and Commentary

Related News and Articles

Caps

How do you think MIPI will perform vs the S&P 500?

Add Stock to Watchlist

All Members

34 Outperform
17 Underperform
 

All-Star Members

12 Outperform
7 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top MIPI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Justin5342002 (76.41)
Submitted August 12, 2007

The company currently has no drugs on the market which I would imagine no product on the market + expenses = low or declining stock price short term, however,

Their two oncology drugs Azedra and Onalta both have orphan drug status which… More

2 Comments | Reply | Report this Post

zzlangerhans (99.36)
Submitted May 11, 2009

The bear rally is dredging up a number of baby bios that I had thought were dead to CAPS. I've red thumbed Molecular Insight before, but without the fortitude to follow them down to a market cap of 36M. Now they are back up to 108M. I've read about… More

1 Comment | Reply | Report this Post
MIPI VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about MIPI.

Recs

0
Member Avatar cashsage (60.05) Submitted: 11/4/2009 3:19:00 PM : Underperform Start Price: $4.68 MIPI Score: +5.45

MIPI has a too high valuation compared to its sales potential. It is also very loss making at least until 2011.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar ssimo2005 (< 20) Submitted: 6/19/2009 11:45:31 AM : Outperform Start Price: $6.09 MIPI Score: -43.52

company is working on a new research "final fase"with own capital, once research is out. stock will boom

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar hennessy7 (< 20) Submitted: 5/31/2008 2:52:46 PM : Outperform Start Price: $7.00 MIPI Score: -15.45

Like the sector and recent buying.

Report this Post 0 Comments | Reply | Permalink
View All 7 Pitches »

Leaderboard

Find the members with the highest scoring picks in MIPI.

Score Leader

Pureunderperform

Pureunderperform (83.70) Score: +56.70

The Score Leader is the member with the highest score across all their picks in MIPI.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
adambward 61.33 6/18/2009 Underperform 3W $6.95 -35.54% +18.06% +53.60
ahknaten 81.96 9/28/2009 Underperform 5Y $5.90 -24.07% +1.04% +25.11
crossbreed < 20 7/13/2007 Underperform 1Y $9.12 -50.88% -27.04% +23.84
BetapegLLC 83.29 9/14/2009 Underperform 5Y $5.46 -17.95% +3.62% +21.57
Mactalon 97.25 7/27/2007 Underperform 5Y $8.06 -44.42% -23.91% +20.51 1 Comment
Styex 64.26 7/31/2007 Underperform NS $8.00 -44.00% -23.97% +20.03
libertybrewcity < 20 9/15/2009 Underperform 1Y $5.47 -18.16% +1.76% +19.92
payroll1 63.05 5/12/2008 Underperform 5Y $7.35 -39.05% -20.21% +18.83
wackyfunster 94.34 4/8/2008 Underperform 5Y $6.69 -33.03% -18.45% +14.58
SirCharms < 20 6/10/2009 Underperform 5Y $4.47 +0.22% +13.38% +13.15
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackBreanMurray 89.84 10/15/2009 Outperform NS $5.39 -16.88% -1.52% -15.37
TrackRBCCapMkts 81.74 5/15/2008 Outperform NS $8.31 -46.09% -21.34% -24.75
TrackWachovia 35.10 10/11/2007 Outperform NS $7.25 -38.21% -28.48% -9.73
TrackJefferies 75.83 3/14/2007 Outperform NS $13.69 -67.28% -17.86% -49.42

Featured Broker Partners